Neuro-Oncology
Reviews

Volume 21 Number 11
November 2019

Home > Publications > Neuro-Oncology Reviews > Volume 21, Year 2019 > Number 11, November

Kaina B.
Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy. Comment on Strobel et al., Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 2019, 7, 69.
Biomedicines. 2019 Nov 11. 2019;7(4):90. doi: 10.3390/biomedicines7040090. _
Refers to:
Strobel H, et al.,Temozolomide and Other Alkylating Agents in Glioblastoma Therapy.
Biomedicines. 2019 Sep 9. 2019;7(3):69. doi: 10.3390/biomedicines7030069. _

Valdebenito S, D'Amico D, Eugenin E.
Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools.
Cancer Rep (Hoboken). 2019 Nov 11. 2019;2(6):e1220. doi: 10.1002/cnr2.1220. Review. _

Kline-Quiroz C, Nori P, Stubblefield MD.
Cancer Rehabilitation: Acute and Chronic Issues, Nerve Injury, Radiation Sequelae, Surgical and Chemo-Related, Part 1.
Med Clin North Am. 2019 Nov 23. 2020;104(2):239-250. Doi:10.1016/j.mcna.2019.10.004. _

Mathen P, Rowe L, Mackey M, Smart D, Tofilon P, Camphausen K.
Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma.
Neurooncol Pract. 2019 Nov 30. 2020;7(3):268-276. doi: 10.1093/nop/npz057. Review. _

Baliga S, Yock TI.
Pediatric Cancer.
Hematol Oncol Clin North Am. 2019 Oct 31. 2020;34(1):143-159. doi: 10.1016/j.hoc.2019.08.021. _

Farooqi A, Li J, de Groot J, Yeboa DN.
Current Role of Radiation Therapy in the Management of Malignant Central Nervous System Tumors.
Hematol Oncol Clin North Am. 2019 Oct 28. 2020;34(1):13-28. doi: 10.1016/j.hoc.2019.08.015. _

Girardi F, Allemani C, Coleman MP.
Worldwide Trends in Survival From Common Childhood Brain Tumors: A Systematic Review.
J Glob Oncol. 2019 Nov 11. 2019;5:1-25. doi: 10.1200/JGO.19.00140. _

He W, Jing Y, Wan Q, Xiao K, Chen K, Lu Y, Li L, Tang Y, Deng Y, Yao Z, Yue J, Cao G.
The anatomy and metabolome of the lymphatic system in the brain in health and disease.
Brain Pathol. 2019 Nov 20. doi: 10.1111/bpa.12805. _

Kis B, Ifrim FC, Buda V, Avram S, Pavel IZ, Antal D, Paunescu V, Dehelean CA, Ardelean F, Diaconeasa Z, Soica C, Danciu C.
Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.
Int J Mol Sci. 2019 Nov 25. 2019;20(23). doi: 10.3390/ijms20235905. _

Lucas CG, Solomon DA, Perry A.
A review of recently described genetic alterations in central nervous system tumors.
Hum Pathol. 2019 Oct 30. doi: 10.1016/j.humpath.2019.10.009. _

Rey-Casserly C, Diver T.
Late effects of pediatric brain tumors.
Curr Opin Pediatr. 2019 Dec;31(6):789-796. doi: 10.1097/MOP.0000000000000837. _

▲

Albano D, Tomasini D, Bonù M, Giubbini R, Bertagna F.
¹⁸F-Fluciclovine (¹⁸F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas.
Ann Nucl Med. 2019 Nov 26. doi: 10.1007/s12149-019-01426-w. _

Bilmin K, Kujawska T, Grieb P.
Sonodynamic Therapy for Gliomas. Perspectives and Prospects of Selective Sonosensitization of Glioma Cells.
Cells. 2019 Nov 13. 2019;8(11). doi: 10.3390/cells8111428. _

Jung E, Alfonso J, Osswald M, Monyer H, Wick W, Winkler F.
Emerging intersections between neuroscience and glioma biology.
Nat Neurosci. 2019 Nov 12. 2019;22(12):1951-1960. doi: 10.1038/s41593-019-0540-y. _

Karpel-Massler G, Nguyen TTT, Shang E, Siegelin MD.
Novel IDH1-Targeted Glioma Therapies.
CNS Drugs. 2019 Nov 25. 2019;33(12):1155-1166. doi: 10.1007/s40263-019-00684-6. _

Lim-Fat MJ, Wen PY.
Glioma progression through synaptic activity.
Nat Rev Neurol. 2019 Nov 19. doi: 10.1038/s41582-019-0290-1. _

Linhares P, Ferreira A, Vaz R.
The importance of the neutrophil-to-lymphocyte ratio in the prognosis of glioma and its subtypes.
CNS Neurosci Ther. 2019 Nov 15. doi: 10.1111/cns.13270. _

Waker CA, Lober RM.
Brain Tumors of Glial Origin.
Adv Exp Med Biol. 2019 Nov 24. 2019;1190:281-297. doi: 10.1007/978-981-32-9636-7_18. _

Zhuo C, Xun Z, Hou W, Ji F, Lin X, Tian H, Zheng W, Chen M, Liu C, Wang W, Chen C.
Surprising Anticancer Activities of Psychiatric Medications: Old Drugs Offer New Hope for Patients With Brain Cancer.
Front Pharmacol. 2019 Oct 22. 2019;10:1262. doi: 10.3389/fphar.2019.01262. _

Kim YZ, Kim CY, Lim J, Sung KS, Lee J, Oh HJ, Kang SG, Kang SH, Kong DS, Kim SH, Kim SH, Kim SH, Kim YJ, Kim EH, Kim IA, Kim HS, Roh TH, Park JS, Park HJ, Song SW, Yang SH, Yoon WS, Yoon HI, Lee ST, Lee SW, Lee YS, Wee CW, Chang JH, Jung TY, Jung HL, Cho JH, Choi SH, Choi HS, Hong JB, Lim DH, Chung DS; KSNO Guideline Working Group.
The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01.
Brain Tumor Res Treat. 2019 Oct 29. 2019;7(2):63-73. doi: 10.14791/btrt.2019.7.e42. _

Kiyokawa J, Wakimoto H.
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma.
Oncolytic Virother. 2019 Oct 24. 2019;8:27-37. doi: 10.2147/OV.S196403. _

Loya J, Zhang C, Cox E, Achrol AS, Kesari S.
Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins.
CNS Oncol. 2019 Nov 21. 2019;8(3):CNS38. doi: 10.2217/cns-2019-0001. _

Loya J, Zhang C, Cox E, Achrol AS, Kesari S.
Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy.
CNS Oncol. 2019 Nov 21. 2019;8(3):CNS40. doi: 10.2217/cns-2019-0002. _

Siegelin MD, Schneider E, Westhoff MA, Wirtz CR, Karpel-Massler G.
Current state and future perspective of drug repurposing in malignant glioma.
Semin Cancer Biol. 2019 Nov 14. doi: 10.1016/j.semcancer.2019.10.018. _

Tamura R, Miyoshi H, Yoshida K, Okano H, Toda M.
Recent progress in the research of suicide gene therapy for malignant glioma.
Neurosurg Rev. 2019 Nov 28. doi: 10.1007/s10143-019-01203-3. _

Kim YZ, Kim CY, Wee CW, Roh TH, Hong JB, Oh HJ, Kang SG, Kang SH, Kong DS, Kim SH, Kim SH, Kim SH, Kim YJ, Kim EH, Kim IA, Kim HS, Park JS, Park HJ, Song SW, Sung KS, Yang SH, Yoon WS, Yoon HI, Lee J, Lee ST, Lee SW, Lee YS, Lim J, Chang JH, Jung TY, Jung HL, Cho JH, Choi SH, Choi HS, Lim DH, Chung DS; KSNO Guideline Working Group.
The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01.
Brain Tumor Res Treat. 2019 Oct 29. 2019;7(2):74-84. doi: 10.14791/btrt.2019.7.e43. _

McDuff SGR, Dietrich J, Atkins KM, Oh KS, Loeffler JS, Shih HA.
Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.
Cancer Med. 2019 Nov 7. doi: 10.1002/cam4.2686. _

▲

Ahmadi-Beni R, Najafi A, Savar SM, Mohebbi N, Khoshnevisan A.
Role of dimethyl fumarate in the treatment of glioblastoma multiforme: A review article.
Iran J Neurol. 2019 Jul 6;18(3):127-133. _

Altinoz MA, Ozpinar A, Ozpinar A, Hacker E, Elmaci İ.
Hypothesis: Could Hepatitis B vaccine act as an immune adjuvant in glioblastoma? Clues to conduct further epidemiological analyses.
Int Immunopharmacol. 2019 Nov 19. 2019;106038. doi: 10.1016/j.intimp.2019.106038. _

Ardura JA, Rackov G, Izquierdo E, Alonso V, Gortazar AR, Escribese MM.
Targeting Macrophages: Friends or Foes in Disease?
Front Pharmacol. 2019 Oct 23. 2019;10:1255. doi: 10.3389/fphar.2019.01255. _

Barkley D, Yanai I.
Plasticity and Clonality of Cancer Cell States.
Trends Cancer. 2019 Nov;5(11):655-656. doi: 10.1016/j.trecan.2019.09.002. Epub 2019 Oct 14.
Source _ Similar articles
Refers to: Neftel C, et al.,An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell. 2019 Jul 18. 2019;178(4):835-849.e21. doi: 10.1016/j.cell.2019.06.024. _

Bruinsmann FA, Richter Vaz G, de Cristo Soares Alves A, Aguirre T, Raffin Pohlmann A, Stanisçuaski Guterres S, Sonvico F.
Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
Molecules. 2019 Nov 26. 2019;24(23). doi: 10.3390/molecules24234312. _

Deng Z, Sheng Z, Yan F.
Ultrasound-Induced Blood-Brain-Barrier Opening Enhances Anticancer Efficacy in the Treatment of Glioblastoma: Current Status and Future Prospects.
J Oncol. 2019 Nov 3. 2019;2019:2345203. doi: 10.1155/2019/2345203. _

Feldheim J, Kessler AF, Monoranu CM, Ernestus RI, Löhr M, Hagemann C.
Changes of O⁶-Methylguanine DNA Methyltransferase (MGMT) Promoter Methylation in Glioblastoma Relapse-A Meta-Analysis Type Literature Review.
Cancers (Basel). 2019 Nov 21. 2019;11(12). doi: 10.3390/cancers11121837. _

Gupta SK, Kizilbash SH, Daniels DJ, Sarkaria JN.
Editorial: Targeted Therapies for Glioblastoma: A Critical Appraisal.
Front Oncol. 2019 Nov 12.2019;9:1216. doi: 10.3389/fonc.2019.01216. _

Jena L, McErlean E, McCarthy H.
Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme.
Drug Deliv Transl Res. 2019 Nov 14. doi: 10.1007/s13346-019-00679-2. _

Kaka N, Hafazalla K, Samawi H, Simpkin A, Perry J, Sahgal A, Das S.
Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis.
Cancers (Basel). 2019 Nov 4.2019;11(11). doi: 10.3390/cancers11111723. _

Liao G, Zhao Z, Yang H, Li X.
Efficacy and Safety of Hypofractionated Radiotherapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme: A Systematic Review and Meta-Analysis.
Front Oncol. 2019 Oct 14. 2019;9:1017. doi: 10.3389/fonc.2019.01017. _

Müller Bark J, Kulasinghe A, Chua B, Day BW, Punyadeera C.
Circulating biomarkers in patients with glioblastoma.
Br J Cancer. 2019 Oct 31. doi: 10.1038/s41416-019-0603-6. _

Sasaki Y.
Nuclear oncology as seen by me in Japan: a historical review and future perspective.
Ann Nucl Med. 2019 Oct 30. doi: 10.1007/s12149-019-01413-1. _

Tan DC, Roth IM, Wickremesekera AC, Davis PF, Kaye AH, Mantamadiotis T, Stylli SS, Tan ST.
Therapeutic Targeting of Cancer Stem Cells in Human Glioblastoma by Manipulating the Renin-Angiotensin System.
Cells. 2019 Oct 31. 2019;8(11). doi: 10.3390/cells8111364. _

Tang X, Zhang S, Fu R, Zhang L, Huang K, Peng H, Dai L, Chen Q.
Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma.
Front Oncol. 2019 Nov 8. 2019;9:1208. doi: 10.3389/fonc.2019.01208. _

Wang WL, Aru N, Liu Z, Shen X, Ding YM, Wu SJ, Qin HH, Jin WY.
Prognosis of patients with newly diagnosed glioblastoma treated with molecularly targeted drugs combined with radiotherapy vs temozolomide monotherapy: A meta-analysis.
Medicine (Baltimore). 2019 Nov 11. 2019;98(45):e17759. doi: 10.1097/MD.0000000000017759. _

▲

Ritchey AK et al., PDQ Pediatric Treatment Editorial Board.
Childhood Ependymoma Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Sum. 2019 Nov 22. NCBI Bookshelf: NBK65742. _

▲

Joshi P, Katsushima K, Zhou R, Meoded A, Stapleton S, Jallo G, Raabe E, Eberhart CG, Perera RJ.
The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma.
Neurooncol Adv. 2019 Sep 6. 2019;1(1):vdz023. doi: 10.1093/noajnl/vdz023. _

Tamayo-Orrego L, Charron F.
Recent advances in SHH medulloblastoma progression: tumor suppressor mechanisms and the tumor microenvironment.
F1000Res. 2019 Oct 29. 2019;8. doi: 10.12688/f1000research.20013.1. _

▲

Beutler BD, Nguyen ET, Parker RA, Tran C, Acharya J, Torres FA, Gullapalli N.
Metastatic meningioma: Case report of a WHO grade I meningioma with liver metastases and review of the literature.
Radiol Case Rep. 2019 Nov 15. 2019;15(2):110-116. doi: 10.1016/j.radcr.2019.10.027. _

▲

Cassina M, Frizziero L, Opocher E, Parrozzani R, Sorrentino U, Viscardi E, Miglionico G, Midena E, Clementi M, Trevisson E.
Optic Pathway Glioma in Type 1 Neurofibromatosis: Review of Its Pathogenesis, Diagnostic Assessment, and Treatment Recommendations.
Cancers (Basel). 2019 Nov 14. 2019;11(11). doi: 10.3390/cancers11111790. _

Flower H, Gallo P.
Cerebellar glioblastoma in an NF1 patient. Is it surgical debulking really necessary?
Br J Neurosurg. 2019 Nov 20. 2019:1-3. doi: 10.1080/02688697.2019.1690127. _

▲